Late-onset Alzheimer's disease is the most common dementia type, yet no treatment exists to stop the neurodegeneration. Evidence from monogenic lysosomal diseases, neuronal pathology and experimental models suggest that autophagic and endolysosomal dysfunction may contribute to neurodegeneration by disrupting the degradation of potentially neurotoxic molecules such as amyloid-b and tau. However, it is uncertain how well the evidence from rare disorders and experimental models capture causal processes in common forms of dementia, including late-onset Alzheimer's disease. For this reason, we set out to investigate if autophagic and endolysosomal genes were enriched for genetic variants that convey increased risk of Alzheimer's disease; such a finding would provide population-based support for the endolysosomal hypothesis of neurodegeneration. We quantified the collective genetic associations between the endolysosomal system and Alzheimer's disease in three genome-wide associations studies (combined n = 62 415). We used the Mergeomics pathway enrichment algorithm that incorporates permutations of the full hierarchical cascade of SNP-gene-pathway to estimate enrichment. We used a previously published collection of 891 autophagic and endolysosomal genes (denoted as AphagEndoLyso, and derived from the Lysoplex sequencing platform) as a proxy for cellular processes related to autophagy, endocytosis and lysosomal function. We also investigated a subset of 142 genes of the 891 that have been implicated in Mendelian diseases (MenDisLyso). We found that both gene sets were enriched for genetic Alzheimer's associations: an enrichment score 3.67 standard deviations from the null model (P = 0.00012) was detected for AphagEndoLyso, and a score 3.36 standard deviations from the null model (P = 0.00039) was detected for MenDisLyso. The high enrichment score was specific to the AphagEndoLyso gene set (stronger than 99.7% of other tested pathways) and to Alzheimer's disease (stronger than all other tested diseases). The APOE locus explained most of the MenDisLyso signal (1.16 standard deviations after APOE removal, P = 0.12), but the AphagEndoLyso signal was less affected (3.35 standard deviations after APOE removal, P = 0.00040). Additional sensitivity analyses further indicated that the AphagEndoLyso Gene Set contained an aggregate genetic association that comprised a combination of subtle genetic signals in multiple genes. We also observed an enrichment of Parkinson's disease signals for MenDisLyso (3.25 standard deviations) and for AphagEndoLyso (3.95 standard deviations from the null model), and a brainspecific pattern of gene expression for AphagEndoLyso in the Gene Tissue Expression Project dataset. These results provide evidence that a diffuse aggregation of genetic perturbations to the autophagy and endolysosomal system may mediate late-onset Alzheimer's risk in human populations.
Introduction
The number of people with dementia is expected to reach 131.5 million by 2050 according to the World Alzheimer Report 2015, Alzheimer's Disease International. Late-onset Alzheimer's disease is the most common type of dementia, and it accounts for up to half of all cases (Goodman et al., 2017) . Currently there is no treatment available to reverse or halt the progression of the disease, thus the human, societal and economic costs due to Alzheimer's disease are rising rapidly as the world population grows older (Brayne and Miller, 2017) .
Across the dementia spectrum, progressive cognitive decline is typically accompanied by abnormal accumulation of specific proteins in the brain (Rahimi and Kovacs, 2014) . In Alzheimer's disease, insoluble extracellular amyloid-b plaques and intraneuronal protein tau tangles are the characteristic features (Bloom, 2014) . How and why the plaques accumulate in late-onset Alzheimer's is not fully understood, but several biological systems are suspected to be involved (Hong et al., 2010; Jones et al., 2010; Lipinski et al., 2010; Ramanan et al., 2012; McBrayer and Nixon, 2013; Lee and Song, 2015; Li et al., 2015; Zhang et al., 2015; Chen et al., 2016; Ciryam et al., 2016; Smith et al., 2016; Hu et al., 2017) . Our aim is to evaluate available genetic evidence for the involvement of the autophagic and endolysosomal system in the development of late-onset Alzheimer's disease.
Removal of unusable cellular material is essential for neuronal health and it is facilitated by an efficient lysosomal system (Settembre et al., 2013) . The lysosome, a membranebound organelle with an acidic interior, is the end-terminal in the wider lysosomal system that collects, transports and recycles material such as foreign particles (phagocytosis), organelles such as mitochondria (autophagy), or macromolecules from the plasma membrane (endocytosis). In particular, amyloid-b and amyloid precursor protein (APP) are carried in endosomes and degraded by the lysosome (Choy et al., 2012; Yuan et al., 2014; Xiao et al., 2015) . In early-onset Alzheimer's with a known origin, dysfunctional presenilin 1 (PSEN1) is the most common cause (Larner and Doran, 2009) . Besides its role in amyloid processing, dysfunctional PSEN1 may result in a defective proton pump (a vacuolarATPase subunit) in the lysosomal membrane, which raises the pH within lysosomes thus impairing their proteolytic ability that is dependent on the acidic environment (Lee et al., 2010 . Furthermore, severe childhood neurodegeneration is a common feature in human lysosomal storage diseases (Cox and Cachó n-González, 2012) , and the underlying genetic variants may also contribute to Parkinson's disease (Robak et al., 2017) . Importantly, lysosomal storage disease also results in the accumulation of proteins related to Alzheimer's disease (Whyte et al., 2017) .
Large-scale genome-wide associations studies (GWAS) provide an opportunity to investigate the endolysosomal hypothesis in human populations (Lambert et al., 2013; Bras et al., 2014; Cruchaga et al., 2014) . Previous studies have already confirmed apolipoprotein E (APOE) alleles as the primary mediators of genetic risk for Alzheimer's disease (Lambert et al., 2013; Calero et al., 2015) , but a large proportion of the heritability remains unexplained. In total, the GWAS Catalog (MacArthur et al., 2017) contains 149 late-onset Alzheimer's disease associations that are considered genome-wide significant (P 5 5 Â 10 À8 , July 2017). The specific goal of this study was to test if the genetic variants that convey Alzheimer's risk occur near or within autophagic and endolysosomal genes more frequently than could be expected by chance.
In this study, we addressed three questions: (i) is there is an aggregate genetic association between the autophagic and endolysosomal system and Alzheimer's disease; (ii) is the aggregate signal unique to Alzheimer's disease compared with other diseases; and (iii) is the signal unique to the autophagic and endolysosomal system. While answering the first question was the main goal of this study, the latter are necessary for ruling out methodological and other artefacts. We used a set of 891 genes as a proxy for the wider autophagic and endolysosomal system (denoted as 'AphagEndoLyso'), and a subset of 142 genes that have been implicated in Mendelian diseases (denoted as 'MenDisLyso'). We used three datasets of late-onset Alzheimer's disease for the first question, and multiple genetic and pathway resources for the other two questions to ensure robust results. In addition, we explored the origins of the aggregate statistical signal, including the role of APOE, to gain insight into the genetic architecture of Alzheimer's disease. These results provide the first largescale genetic evidence on the special importance of the autophagic and endolysosomal system in the development of Alzheimer's disease.
Materials and methods

GWAS datasets
We obtained single nucleotide polymorphism (SNP) association statistics from the International Genomics of Alzheimer's Project (IGAP) (Lambert et al., 2013) , from the African American component of the Alzheimer Disease Genetics Consortium (AA-ADGC) (Reitz et al., 2013) , and from the Alzheimer's Disease Sequencing Project (ADSP) (Harold et al., 2009) . IGAP summary statistics of 17 008 cases and 37 154 controls with European ancestry (NIAGADS ID: NG00036) were estimated by the original project team (Lambert et al., 2013) . Similarly, the AA-ADGC summary statistics for 1968 cases and 3928 controls (NIAGADS ID: NG00039) were estimated by the original investigators (Reitz et al., 2013) . The genetic variants in the ADSP dataset of 5777 cases and 5136 controls (Harold et al., 2009) were derived from raw exome sequencing data by the ADSP QC Working Group (dbGaP ID: phs000572.v6.p4). For this study, we estimated association statistics for both rare and common variants. A total of 8556 individuals were shared between the ADSP (78% of 10 913) and IGAP (16% of 54 162, Jaccard index 15%). In addition, we accessed 70 publicly available disease GWAS via the GRASP website (Leslie et al., 2014) We estimated Alzheimer's associations in the ADSP dataset with Plink v1.9 (Purcell et al., 2007) and the R package GenABEL (Karssen et al., 2016) . We used the minor allele frequency (MAF) to define rare (0.1% 4 MAF 5 1%) and common (MAF 5 1%) variants. To estimate associations with rare variants, we used the gene burden tool in Plink (PLINK/ SEQ 0.10, option '-tests burden'): the test statistic was defined as the difference between the mean counts of rare alleles in the cases versus the controls (one-sided, only positive values considered), divided by the variance in allele counts. The variance in the denominator was estimated as the root mean square of group-specific deviations from the mean. To estimate the P-value, the null distribution of the test statistic was simulated via random permutations of the case-control labels. For the common variants, we used age-dependent Cox regression in GenABEL under additive allele effects and with sex and principal components of population structure as covariates. We used PLINK to estimate 20 principal components according to the variance-standardized relationship matrix; the relationship matrix was estimated from SNPs that were pruned for linkage disequilibrium with a sliding window of 1 Mbp in 100-bp increments.
To integrate gene burden statistics with SNP associations, we represented the burden P-values as if they were from a single SNP within the gene. The resulting data format comprised the fields SNP, Chromosome, Position and P-value, where the pseudo-SNP was a unique identifier and chromosome and position were set at the centre of the gene region. Subsequent analyses proceeded as if the data were from a standard GWAS.
Pathway resources
For brevity, we use the term 'pathway' when referring to any set of potentially co-operating genes, whether they come from a true molecular or canonical pathway, or have been grouped together because of other biological associations.
Before any analyses, we reviewed relevant literature to define an accurate gene set as a proxy for the endolysosomal system. Lysoplex is a targeted sequencing toolkit for the identification of mutations among genes involved in autophagy and lysosomal pathways (Di Fruscio et al., 2015) . It contains 891 genes, including autophagy genes, lysosomal genes, lysosomal storage disorders related genes and genes in endocytic pathways (overlaps with canonical pathways are listed in the Supplementary material, part 2). We denote this broad collection as the AphagEndoLyso Gene Set. Among the 891 genes, 142 genes harbour known Mendelian disease mutations. We denote the smaller set as the MenDisLyso Gene Set.
To investigate the specificity of the lysosomal pathway signals, we created a non-targeted collection of pathways. We included pathways that contained between 20 and 1000 genes, as this provides the most reliable enrichment signals in our experience (Shu et al., 2016) . We obtained 693 canonical pathways from the MSigDB (Liberzon et al., 2015) , sourced from Kyoto Encyclopedia of Genes and Genomes (KEGG), BioCarta and Reactome. We also downloaded 491 gene sets from the Drug Signature Database (DSigDB) (Yoo et al., 2015) . To complement the curated resources, we collected 333 empirical pathways from two gene expression studies of brain biopsies (Zhang et al., 2013; Narayanan et al., 2014) .
Pathway enrichment analysis
To investigate the aggregate genetic link between the autophagic and endolysosomal system and Alzheimer's disease, we applied pathway enrichment analysis (Khatri et al., 2012) . We recently developed the Marker Set Enrichment Analysis (MSEA) algorithm in Mergeomics to estimate genetic associations between pathways and diseases (Shu et al., 2016) . The MSEA incorporates a three-tier pathway-gene-locus hierarchy within a statistical permutation engine, which eliminates confounding effects from gene size, and removes spurious signals due to linkage disequilibrium or atypical areas of genetic variation (e.g. the HLA region on chromosome 6). Unlike overrepresentation or conventional gene scoring algorithms, MSEA uses all available SNPs to estimate null distributions, which reduces bias from SNP selection. Furthermore, the output includes the empirical Z-score of enrichment in addition to a permutation-based P-value. A high Z-score for a pathway means that the SNPs assigned upstream of pathway member genes show stronger Alzheimer's disease associations than could be expected for a random set of genes.
The assignment of downstream gene targets for SNPs affects the statistical power (number of assigned SNP-gene pairs) and sensitivity of the analysis (noise from erroneous assignments). Based on previous studies (Mä kinen et al., 2014; Shu et al., 2016) , we applied systematic assignment of SNPs to expanded gene regions ( AE 50 kbp around exons). Of note, tissue-specific expression quantitative trait loci (eQTLs) from the literature were inferior to the distance-based assignment because of a low number of loci and limited coverage across the genome (data not shown). SNPs close to each other may be in linkage disequilibrium (LD), which can bias enrichment scores. For this reason, we applied priority filtering with a minimum gap of 2 kbp to dilute clusters of closely-packed SNPs (Mä kinen et al., 2014).
Meta-analysis
Under the null hypothesis, the enrichment score Z follows the standard normal distribution with zero mean and unit variance. The sum of Zs from different experiments is also a normally distributed variable that can be standardized back to unit variance (denoted as Z meta ). This is beneficial, since we can assess the statistical significance (P-value) of the combined enrichment signal by the value of the cumulative standard normal curve at Z meta . As the GWAS varied in size and some individuals participated in both the ADSP and IGAP (Fig. 1) , we estimated Z meta using a weighted formula that facilitates correlated inputs (Zaykin, 2011) . We used the square root of sample size to weight the mean of the enrichment scores, and we estimated the overlap as a correlation according to Equation 7 in Lin and Sullivan (2009) . The correlation between ADSP and IGAP was r = 0.35 and, together with the sample sizes, produced the formula:
Gene sensitivity analysis
To investigate the contribution of single genes to the overall enrichment Z-score, we removed all the SNPs near a gene before re-estimating the score. Subsequently, we defined the gene-specific contribution as the difference between the original and the re-estimated score. Visual inspection of the IGAP statistics revealed that APOE exhibited the widest linkage disequilibrium block of 800 kbp, therefore we used a window of AE 400 kbp to make sure all SNPs in linkage disequilibrium were removed near a gene. Enrichment scores remained similar when AE 600 kbp, AE800 kbp or AE1 Mbp were removed.
All statistical analyses were conducted using the algorithms within the Mergeomics package (Shu et al., 2016) , statistical tools within R v3.4.0, and in-house software.
Data availability
Summary statistics for the ADSP dataset and other supporting material are available in the Supplementary material, part 7.
Results
Aggregate genetic association between autophagic and endolysosomal genes and Alzheimer's disease
Pathway enrichment results for the endolysosomal system are listed in Table 1 . We observed a nominal enrichment signal (P 5 0.05) across most of the GWAS, with statistically significant scores in the meta-analysis both for MedDisLyso (Z = 3.49, P = 0.00024) and AphagEndoLyso (Z = 3.59, P = 0.00017). Here, the Z-score indicates the deviation from the mean of the null model as multiples of standard deviations (SDs) of the null distribution.
The APOE locus in chromosome 19 is the strongest single genetic predictor of late-onset Alzheimer's disease (Lambert et al., 2013) and APOE was present within both lists of autophagic and endolysosomal system genes obtained from the Lysoplex sequencing platform. To confirm that we observed an aggregate genetic signal rather than a single locus, we removed all SNPs close to the APOE locus ( AE400 kbp) from the GWAS summary data prior to statistical analysis. While the pathway signal for the MedDisLyso Gene Set diminished substantially (Z = 1.23), the enrichment score for the Extended Lysosome gene set remained high (Z = 3.37).
Specificity to Alzheimer's over other diseases
Spurious positive pathway signals may arise if the pathway genes are clustered in the same chromosomal region. For instance, the major histocompatibility complex on chromosome 6 produces strong signals for most diseases partly due to its unusual genetic variation (Handunnetthi et al., 2010) . To ensure the pathway method itself did not generate positive signals for the lysosomal pathways, we compared the meta-LOAD (late-onset Alzheimer's disease) signals against a collection of other disease GWAS (Fig. 2) . The meta-LOAD signals were at the top of the list for both MedDisLyso (stronger than 97.9% of other GWAS, Fig. 2A ) and AphagEndoLyso (the strongest signal, Fig. 2B ). We also observed a subtle shift towards higher values in the distribution of the enrichment scores (P = 0.36 for MenDisLyso and P = 0.0075 for AphagEndoLyso by the Shapiro-Wilk normality test) but, overall, there was no evidence of methodological problems. It is also possible that there is genetic overlap between lysosomal and other disease-causing pathways, which results in shared signals. For instance, the top Parkinson's disease GWAS (Nalls et al., 2014) produced a signal of Z = 3.95 for MenDisLyso and Z = 3.25 for AphagEndoLyso, and we observed Z = 1.8 (MenDisLyso) and Z = 2.2 (AphapEndoLyso) for Crohn's disease (Franke et al., 2010) .
APOE isoforms (i.e. major genetic variants of APOE) are likely to modulate multiple phenotypic traits, including Alzheimer's disease (Lambert et al., 2013; Tudorache et al., 2017) . For this reason, we repeated the above analyses with the APOE locus removed to confirm that the observed histogram did not arise from APOE alone (Fig. 2C and D) . The signal for MenDisLyso was reduced after removing APOE (Z = 1.23, Fig. 2C) ; however, the signal for AphagEndoLyso was less affected (Z = 3.37 after APOE removal, Fig. 2D ). No substantial changes were observed in either the top Parkinson's (Z = 3.81 for MenDisLyso and Z = 3.25 for AphagEndoLyso) or Crohn's disease score (Z = 1.76 for MenDisLyso and Z = 2.21 for AphagEndoLyso). The overall shape of the enrichment score distribution across all diseases was not affected by APOE removal (P = 1.0 for both MenDisLyso and AphagEndoLyso by two-sample Kolmogorov-Smirnov test).
Specificity to the lysosomal system over other pathways
Next, we compared the lysosomal pathways with both curated and empirical gene sets to further rule out spurious causes for the observed enrichment (Fig. 3) . Overall, the lysosomal pathways were at the top of the list in all comparisons: only 0.7% of canonical pathways, 0.2% of drug signatures and 0.3% of empirical gene sets associated with neurodegeneration outperformed MenDisLyso, and 0.3% of canonical pathways, 0.2% of drug signatures and 0.3% of empirical gene sets exceeded the aggregate signal from AphagEndoLyso (Supplementary material, part 3). Of note, there were canonical lysosome and endocytosis pathways, but they did not show strong signals for AphagEndoLyso in the meta-analysis (Z = 1.83 for KEGG Endocytosis, Z = 0.87 for KEGG Lysosome, and Z = 0.08 for Reactome Lysosome Vesicle Biogenesis).
Contribution of specific genes to aggregate signals
To gain insight into the genetic architecture that generated the pathway signals, we excluded segments of the genome around the pathway genes, one at a time, and compared the enrichment score before and after the exclusion. Figure 4 shows the main findings, including APOE, the removal of which was already addressed in the previous sections. When common variants of genome-wide significance were removed, the aggregate signal disappeared, as expected. On the other hand, when genome regions around genes known to contain rare Alzheimer's disease loci were removed, the aggregate signals were less affected (Fig. 4) .
We sorted the genes according to the results from singlegene removal (with genes that had the highest impact on Z-score at the top of the list) and then removed the corresponding loci in a cumulative fashion starting from the top of the list. We observed a consistent drop in the Z-score until the 15th gene in AphagEndoLyso, and then a substantial drop after APOE at the 54th position (Fig. 5, dotted line) . Interestingly, the fall in Z-score from the subtraction of the first 15 genes in this ordered list is larger than the Z-score reduction induced by the subtraction of APOE alone. We further repeated this analysis by subtracting APOE first before progressing through the cumulative removal of other genes (Fig. 5, dashed line) . This analysis further confirmed that a large proportion of the disease-associated genetic variation within the AphagEndoLyso Gene Set is spread diffusely through numerous endolysosomal pathway genes. Of the top 15, six genes (PICALM, SYTL2, CD2AP, STK11, BIN1 and CR1) harboured genome-wide significant Alzheimer's loci.
Gene expression in the brain
To determine if the gene sets of interest were expressed primarily in the brain, we extracted median transcripts per kilobase million (TPM) for each gene in 53 tissues in the Gene Tissue Expression (GTEx) repository (GTEx Consortium, 2013) . In general, TPM was lower in brain tissues (Supplement 4). We also observed that the median TPM of MenDisLyso or AphagEndoLyso was different from the median TPM of all genes, mainly due to the fact that most entries in the GTEx dataset had very low values (data not shown). To construct an unbiased statistical test, we first calculated the overall median expression over all tissues for each gene, and then selected the subset of genes (denoted as the background) that had the same distribution of all-tissue expression as the genes within MenDisLyso or AphagEndoLyso. Consequently, a random gene set picked from the background is drawn from the same distribution of global expression as the MenDisLyso and AphagEndoLyso gene sets. We used permutation analysis to compare the MedDisLyso and AphagEndoLyso genes against random genes that had the matching all-tissue TPM distribution. We found that MedDisLyso genes tended to have lower median TPM than expected in multiple brain compartments (e.g. À1.80 SDs from expected, two-tailed P = 0.072 for frontal cortex), and the AphagEndoLyso higher than expected TPM ( + 3.60 SDs, P = 0.00033 for frontal cortex). The 749 AphagEndoLyso genes that were not part of MedDisLyso had even higher median TPM in the brain ( + 4.18 SDs, P = 2.9 Â 10 À5 for frontal cortex). This pattern of relative differences was unique to brain tissues (Supplementary material, parts 4 and 5).
Discussion
Late-onset Alzheimer's disease is the most common form of dementia in older individuals, and the prevalence is expected to increase as the world population grows older. Evidence from monogenic diseases and experimental models suggests that autophagy and the endolysosomal system may be mechanistically involved in the neurodegenerative processes in Alzheimer's disease. We observed a significant and specific aggregate signal that provides genetic support for this hypothesis. Furthermore, we demonstrated that the signal was independent of APOE, the major susceptibility locus for late-onset Alzheimer's disease. For this highest ranked genes were successively removed from the two lysosomal pathways. The ranking was based on the effect of removing a single gene; that is, genes that on their own explained a large proportion of the aggregate association were ranked at the top. The curves were produced by cumulative removal of genes in the ranked order (e.g. the value at the 15th position was calculated after removing all the first 15 genes, not just the 15th gene). Please note the gene order is different for each curve. reason, we propose that the cumulative exposure to subtle genetic defects within the autophagic and endolysosomal system may contribute to the development of Alzheimer's disease.
To test the polygenic lysosomal hypothesis, we used pathway-based genetic analysis that captures aggregate associations across multiple loci (Shu et al., 2016) . Previous pathway screening studies of dementia have implicated the immune system (Jones et al., 2010; Ramanan et al., 2012; Chen et al., 2016; Smith et al., 2016; Hu et al., 2017) , neurodevelopment and cell cycle (Ramanan et al., 2012; Lee and Song, 2015; Hu et al., 2017) , lipid and lipoprotein metabolism (Jones et al., 2010; Smith et al., 2016; Hu et al., 2017) , and oxidative stress or mitochondrial function Zhang et al., 2015; Ciryam et al., 2016; Smith et al., 2016) , among others. Importantly, genetic and non-genetic pathway associations have been detected for the plasma membrane, related protein trafficking, autophagy and the lysosomal system (Hong et al., 2010; Lipinski et al., 2010; McBrayer and Nixon, 2013; Smith et al., 2016) .
Our results for AphagEndoLyso may represent a convergence of multiple biological subprocesses, including those mentioned above, that are collectively involved in common forms of dementia. In particular, we found that tens and possibly hundreds of genes may play a role in Alzheimer's disease beyond the genetic APOE variants (Fig. 5) . Of note, almost all genes from the endocytosis and lysosome pathways from KEGG were contained within AphagEndoLyso, yet neither of them produced a significant signal alone. We also replicated the Parkinson's disease signal from rare genetic variants of lysosomal storage diseases (Robak et al., 2017) using common genome-wide variation (Fig. 2) . Is it plausible that so many genes are important? Clinical picture may be a possible explanation: Alzheimer's is common in the elderly, it affects cognitive processes that produce a diverse set of symptoms, and the pathology may include a spectrum of amyloid deposits, vascular dementia and Parkinson's features in the oldest age groups (Rabinovici et al., 2017) . Given the multiple overlapping etiological processes, we would expect to see a diffuse genome-wide signal for late-onset Alzheimer's (more genes needed to capture the aggregate signal).
The predictive role of APOE variants for dementia and longevity is well established in multiple studies (Kim et al., 2009) . Surprisingly, we observed that the aggregate signal for AphagEndoLyso was not affected by the removal of APOE. This could be partly because of methodology: the AphagEndoLyso Gene Set represents a large set of 891 genes, which means that the enrichment algorithm will emphasize the bulk of signals at the expense of a few extreme peaks such as the APOE locus. However, we maintain that this was a sound methodological choice, given that people without the high-risk APOE "4 can also get Alzheimer's disease. Following the sensitivity analysis in Fig. 5 , nine of the top 15 genes (which cumulatively accounted for a large amount of association between the extended lysosomal set and Alzheimer's disease) were not genome-wide significant. This shows that the genetic risk may be spread diffusely among the genes in endolysosomal pathways, and therefore the signal is hard to detect by univariate GWAS screens. The nature of these genes that accounted for so much of the association appeared to be functionally diverse, further supporting the idea that diffuse genetic burden across the entire autophagic and endolysosomal system could drive disease. Among high-impact genes that were not genome-wide significant by themselves were CLN6, a lysosomal storage disorder gene (Mole and Cotman, 2015) ; STK11/LKB1, a gene whose protein controls the AMPK-ULK1 autophagy activation axis (Mihaylova and Shaw, 2011) , and AP2A2, a gene that produces a component of the AP2 complex, which interacts with PICALM to bring about degradation of APP carboxyterminal fragments (Tian et al., 2013) .
We observed lower relative brain expression for MedDisLyso and higher for AphagEndoLyso. As brain cells and neurons especially have elongated morphology, it makes sense that the endosomal transport machinery that delivers cargo to the lysosomes would be highly active. Neurons are particularly efficient at trafficking and fusing autophagosomes with endolysosomes and lysosomes (Boland et al., 2008) . Expression of genes in this pathway may be high because this active network must efficiently move waste materials around distances on the order of meters, inside a single neuron. For instance, estimates of total axonal length for human neurons in the substantia nigra are in excess of 4 m per cell (Hunn et al., 2015) .
The design of this study is both its main strength and limitation. We established the exclusive focus on the lysosomal system before any genetic analyses, which enabled us to avoid the practical challenge of multiple testing. On the other hand, we cannot fully address the existence of other pathway signals without violating the statistical setting, nor can we conclude that the lysosomal system is the pathway with the strongest genetic signal. Indeed, the Lysoplex gene list may not be the optimal way to represent the lysosomal system. For instance, publication bias may have affected the Lysoplex curation effort and further experimental screening is warranted to refine the definitions of the autophagic and endolysosomal systems. From a genetics perspective, our work resembles a candidate gene study, albeit a highpowered one, and the results should be interpreted with the same caveats in mind.
Our methodology was designed to detect aggregate signals scattered across the genome. We developed a rankstratified test statistic that attenuates the impact of extreme signal peaks (Mä kinen et al., 2014; Shu et al., 2016) , while enhancing the collective information contained within multiple independent but weaker associations. Overall, the method is robust: we have previously established the benefits of a hierarchical pathway enrichment algorithm for GWAS, and the usefulness of pathway-level meta-analysis (Shu et al., 2016) . Furthermore, the Gaussian shape of the Z-score distributions (Figs 2 and 3) indicate that the method was calibrated well, and the specificity of the lysosome signal across multiple diseases and other pathways rules out methodological artefacts as the causes for the observed signals.
To our knowledge, this is the first time the autophagic and endolysosomal system has been specifically associated with late-onset Alzheimer's disease via genome-wide genetic variation. In particular, we found an aggregate signal that could not be explained by any single gene, which fits with the polygenic aetiology of Alzheimer's disease. Furthermore, the restricted but high-powered study design shows how systems-based biological hypotheses can be formally tested with human genetics data. Finally, our findings support the important role of the autophagic and endolysosomal system in dementia, and further research on these pathways as a potential avenue to maintain the health of neurons in an ageing brain should be prioritized.
